| mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.018 |
0.8 |
| mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
-0.0075 |
0.9 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
6e-07 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-06 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
3e-06 |